moricizine hcl ( ethmozine ) , a new antiarrhythmic agent , was administered to 102 patients with refractory ventricular fibrillation ( n = 31 ) , sustained ventricular tachycardia ( vt ) ( n = 46 ) or symptomatic nonsustained vt ( n = 25 ) .
C0079856
moricizine
C0003195
antiarrhythmic agent